X4 Pharmaceuticals Inc. (XFOR) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    X4 Pharmaceuticals Inc.

    NASDAQ: XFOR · Real-Time Price · USD
    3.50
    -0.14 (-3.85%)
    At close: Sep 05, 2025, 3:59 PM
    3.54
    1.10%
    After-hours: Sep 05, 2025, 07:42 PM EDT

    X4 Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -3.94 -1.47 -0.65 -0.57
    PEG Ratio
    		 0.06 0.02 0.01 -0.02
    PS Ratio
    		 57.69 n/a n/a n/a
    PB Ratio
    		 6.66 2.92 0.83 0.79
    P/FCF Ratio
    		 -1.12 -1.54 -0.8 -0.71
    P/OCF Ratio
    		 -1.13 -1.55 -0.8 -0.72
    OCF/S Ratio
    		 -51.19 n/a n/a n/a
    Debt / Equity Ratio
    		 3.53 1.14 0.52 0.62
    Quick Ratio
    		 3.33 5.34 5.76 6.27
    Current Ratio
    		 3.41 5.34 5.76 6.27
    Asset Turnover
    		 0.02 n/a n/a n/a
    Interest Coverage
    		 -4.15 -18.61 -21.93 -23.37
    Return on Equity
    		 -1.69 -1.98 -1.27 -1.38
    Return on Assets
    		 -0.26 -0.69 -0.6 -0.76
    Return on Invested Capital
    		 -0.32 -0.85 -0.65 -0.81
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.69 n/a n/a n/a
    Net Profit Margin
    		 -14.65 n/a n/a n/a
    Pretax Profit Margin
    		 -14.52 n/a n/a n/a
    Operating Profit Margin
    		 -14.24 n/a n/a n/a
    FCF Margin
    		 -51.32 n/a n/a n/a
    EBITDA Margin
    		 -10.78 n/a n/a n/a

    Add to Watchlist